CAPABILITIES

We are fully integrated and fully dedicated

Our competencies run deep: from our strong in-house R&D to our sales and marketing.

 

Learn more about our areas of expertise by clicking on each capability.

 

References
  1. Steudel W, Hurford WE, Zapol WM. Inhaled nitric oxide: basic biology and clinical applications. Anesthesiology. 1999;91(4):1090-1121. 
  2. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res. 2007;75(2):339-348.
  3. Dohler KD, Meyer M. Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage. Best Pract Res Clin Anaesthesiol. 2008;22(2):335-350.
  4. Ng CKF, Chan MHM, Tai MHL, Lam CWK. Hepatorenal syndrome. Clin Biochem Rev. 2007;28(1):11-17.
  5. Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388-1396.

 

INOMAX is a registered trademark of INO Therapeutics LLC.